Abstract
The US Army's experience with mumps hospitalizations was examined for the years 1980 through 1986. One hundred fifty-two cases among active duty Army soldiers were identified. Mumps rates declined from 3.85 per 100,000 active duty soldiers per year in 1980 to 1.28 in 1985, but an outbreak during 1986 caused rates to jump to 6.65. Attack rates were found to decline dramatically with increasing age or length of military service, with 74 per cent of cases occurring in soldiers with three years or less of service. Rates for Blacks and Whites were similar, but were higher for other minorities. Complications reported were mild. A cost-benefit analysis, assuming all recruits were to be vaccinated, estimated average annual vaccination program costs of $286,789; this figure exceeds average annual reported hospitalized mumps disease costs of $61,525 by a factor of 4.7. Mumps attack rates would have to reach at least 15.0 per 100,000 per year before savings would equal recruit vaccination costs. Failure to show that a vaccine program would be cost-saving may be due to limitations in identifying cases or to the requirement that all recruits be immunized regardless of prior immune status. It is likely that a program to immunize susceptible individuals alone would show benefit.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BLACK F. L. A NATIONWIDE SERUM SURVEY OF UNITED STATES MILITARY RECRUITS, 1962. 3. MEASLES AND MUMPS ANTIBODIES. Am J Hyg. 1964 Nov;80:304–307. doi: 10.1093/oxfordjournals.aje.a120479. [DOI] [PubMed] [Google Scholar]
- Chaiken B. P., Williams N. M., Preblud S. R., Parkin W., Altman R. The effect of a school entry law on mumps activity in a school district. JAMA. 1987 May 8;257(18):2455–2458. [PubMed] [Google Scholar]
- Cochi S. L., Preblud S. R., Orenstein W. A. Perspectives on the relative resurgence of mumps in the United States. Am J Dis Child. 1988 May;142(5):499–507. doi: 10.1001/archpedi.1988.02150050037025. [DOI] [PubMed] [Google Scholar]
- Harris R. W., Turnbull C. D., Isacson P., Karzon D. T., Winkelstein W., Jr Mumps in a northeast metropolitan community. I. Epidemiology of clinical mumps. Am J Epidemiol. 1968 Sep;88(2):224–233. doi: 10.1093/oxfordjournals.aje.a120881. [DOI] [PubMed] [Google Scholar]
- Kim-Farley R., Bart S., Stetler H., Orenstein W., Bart K., Sullivan K., Halpin T., Sirotkin B. Clinical mumps vaccine efficacy. Am J Epidemiol. 1985 Apr;121(4):593–597. doi: 10.1093/oxfordjournals.aje.a114037. [DOI] [PubMed] [Google Scholar]
- Koplan J. P., Preblud S. R. A benefit-cost analysis of mumps vaccine. Am J Dis Child. 1982 Apr;136(4):362–364. doi: 10.1001/archpedi.1982.03970400080021. [DOI] [PubMed] [Google Scholar]
- LIAO S. J., BENENSON A. S. Immunity status of military recruits in 1951 in the United States. II. Results of mumps complement-fixation tests. Am J Hyg. 1954 May;59(3):273–281. doi: 10.1093/oxfordjournals.aje.a119640. [DOI] [PubMed] [Google Scholar]
- Levitt L. P., Mahoney D. H., Jr, Casey H. L., Bond J. O. Mumps in a general population. A sero-epidemiologic study. Am J Dis Child. 1970 Aug;120(2):134–138. doi: 10.1001/archpedi.1970.02100070078008. [DOI] [PubMed] [Google Scholar]
- PHILIP R. N., REINHARD K. R., LACKMAN D. B. Observations on a mumps epidemic in a virgin population. Am J Hyg. 1959 Mar;69(2):91–111. doi: 10.1093/oxfordjournals.aje.a119992. [DOI] [PubMed] [Google Scholar]
- WERNER C. A. Mumps orchitis and testicular atrophy; occurrence. Ann Intern Med. 1950 Jun;32(6):1066–1074. doi: 10.7326/0003-4819-32-6-1066. [DOI] [PubMed] [Google Scholar]
- White C. C., Koplan J. P., Orenstein W. A. Benefits, risks and costs of immunization for measles, mumps and rubella. Am J Public Health. 1985 Jul;75(7):739–744. doi: 10.2105/ajph.75.7.739. [DOI] [PMC free article] [PubMed] [Google Scholar]